Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.

Genetic testing and molecular biomarkers - 1 Dec 2011

Hashad Doaa I, Abou-Zeid Abla A, Achmawy Ghada A, Allah Horeya M O Saad, Saad Marwa A

Abstract excerpt

AIM: This work investigates the prevalence of G2019S mutation of the leucine-rich repeat kinase 2 (LRRK2) gene in a cohort of Egyptian patients with sporadic Parkinson's disease (PD) and its relation to various features of the disease. MATERIALS AND METHODS: The study included 113 patients with sporadic PD and 87 healthy individuals as a control group. Clinical assessment was done using the Unified PD Rating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Egypt

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Polymorphism, Restriction Fragment Length

Share to Prevalence

Share to Protein Serine-Threonine Kinases

Share to Severity of Illness Index

Source

Identifiers

PMID: 21699405
DOI: 10.1089/gtmb.2011.0016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.PMID 21699405Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s DiseaseSemantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.Semantic proximity Read ↗

The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.Semantic proximity Read ↗

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.Semantic proximity Read ↗

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.Semantic proximity Read ↗

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.Semantic proximity Read ↗

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Semantic proximity Read ↗

LRRK2 R1441C mutation causing Parkinson's Disease in an Egyptian family.Semantic proximity Read ↗

The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.